PC
CCXI

Polar Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Polar Capital’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$44.3M Buy
+808,739
New +$43.5M 0.33% 85
2020
Q2 		– Sell
-250,920
Closed -$10.1M – 328
2020
Q1 		$10.1M Buy
+250,920
New +$10.7M 0.11% 167

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Polar Capital's CCXI Position: Q3 2020 in Review

Polar Capital opened a new position in ChemoCentryx, Inc. (CCXI) in Q3 2020: 808,739 shares worth $44.3M. The stake represents 0.33% of the portfolio and ranks #85 among its holdings. This is a return to the name: Polar Capital previously reported a position in CCXI as recently as Q1 2020.

Polar Capital first reported a position in CCXI in Q1 2020 and has held it in 2 quarters since. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Polar Capital held 808,739 shares of ChemoCentryx, Inc. worth $44.3M as of Q3 2020.
  • ChemoCentryx, Inc. was a new Polar Capital position in Q3 2020.
  • ChemoCentryx, Inc. made up 0.33% of Polar Capital's portfolio in Q3 2020, its #85 holding.
  • Polar Capital first reported a position in ChemoCentryx, Inc. in Q1 2020 and has held it in 2 quarters since.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.